Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Outcomes of the Proprioception and Strengthening Exercise Program in Chronic Plantar Fasciitis

NCT07754214 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-08-01
Last updated
2026-08-20

Condition(s) studied

Plantar Fasciitis, Chronic

Investigational drug(s) / intervention(s)

StretchingProprioception and Stretching ExercisesKnee Strengthening and Stretching Exercises

Stretching: Participants will perform standardized plantar fascia and gastrocnemius-soleus stretching exercises. The protocol consists of stretching twice daily, 7 days per week, for 6 weeks.

Proprioception and Stretching Exercises: In addition to the standard stretching protocol, participants in this group will perform a supervised, 6-week progressive proprioception exercise program administered by a physiotherapist three times per week. Exercises will be performed under both eyes-open and eyes-closed conditions on progressively less stable surfaces with task difficulty advanced on a weekly basis.

Knee Strengthening and Stretching Exercises: In addition to the standard stretching protocol, participants in this group will perform a supervised, 6-week progressive knee-strengthening program administered by a physiotherapist three times per week.

Study summary

Plantar fasciitis is a common cause of heel pain, and although stretching exercises are a standard first-line treatment, current evidence on adding proprioception or knee-strengthening exercises remains limited. This study investigates whether adding knee strengthening or proprioception exercises to a standard stretching program improves pain, function, and disability in patients with chronic plantar fasciitis, and whether these interventions produce measurable changes in the biomechanical and kinesiological properties of the foot, ankle, and knee.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 65 years. * Formal diagnosis of plantar fasciitis, characterized by sharp pain during the first steps in the morning, pain that increases with prolonged activity, localized tenderness on palpation of the medial calcaneal tubercle or proximal fascia, and a positive Windlass test. * Symptom duration of at least 3 months. * Heel pain intensity score of Visual Analog Scale (VAS) \> 3. * Voluntary agreement to participate, evidenced by signing the written informed consent form. Exclusion Criteria: * History of acute lower-extremity trauma. * History of prior foot or ankle surgery. * Corticosteroid injection to the affected heel within the preceding 6 months. * Presence of systemic inflammatory or rheumatologic disease. * Uncontrolled systemic disease (e.g., uncontrolled hypertension, uncontrolled diabetes mellitus). * Current or past history of malignancy. * Current pregnancy. * Body mass index (BMI) ≥ 30 kg/m². * Any musculoskeletal, neuromuscular, ocular, or vestibular disorder that could impair balance or limit the ability to stand unsupported. * Neurocognitive or psychiatric conditions precluding adherence to the exercise protocols or outcome assessments.

Primary outcome measure(s)

  • Pain Intensity (First-Step Morning, Evening, and Overall Daily Pain) — Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 12).
    Pain intensity during the first steps in the morning, before going to bed, and overall daily pain will be assessed using the Visual Analog Scale (VAS). The scale consists of a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst imaginable pain), on which participants mark the point corresponding to their perceived pain level.
  • Pressure Pain Threshold (PPT) — Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 12).
    PPT will be assessed using a Baseline® 12-1442 dolorimeter (22-lb sensitivity range; Fabrication Enterprises Inc., USA) to evaluate deep-tissue mechanical sensitivity. With the participant positioned prone and the feet hanging off the table, gradually increasing pressure will be applied to the midpoint of the plantar fascia insertion at the calcaneus. The pressure at which the participant first perceives pain will be recorded. Three measurements will be taken at 30-second intervals, and the mean value will be used for analysis.
  • Foot Function and Health Status (Revised Foot Function Index, FFI-R) — Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 12).
    The FFI-R is a self-reported, multidimensional questionnaire comprising 68 items across four subscales: pain and stiffness, social and emotional consequences, dysfunction, and activity limitation. Each item is scored from 1 to 4, with higher scores indicating poorer foot health and greater functional limitation.
  • Foot and Ankle Function (Foot and Ankle Outcome Score, FAOS) — Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 12).
    The FAOS is a 42-item self-reported questionnaire assessing five subscales: pain, other symptoms, activities of daily living, sports and recreation, and foot-and-ankle-related quality of life. Each item is scored from 0 to 4.

Trial sites (1)

FacilityCityRegionStatus
Karaman Training and Research Hospital Karaman Karaman Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07754214 on ClinicalTrials.gov ↗ ← All trials in Turkey